Expands access to Fresenius Medical Care's globally established portfolio of advanced kidney replacement therapies in the U.S ...

Revenue of $716.0 million in the third quarter of 2026 increased 8.5% from revenue of $659.9 million for the comparable prior ...

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report third quarter results on November 4, ...

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2026 financial ...

Kardium today announced the first site activation and first patient enrollment in the Globe Registry: Globe ® Pulsed Field ...

Jefferies, Leerink Partners and TD Cowen are acting as joint book-running managers.

HIV treatment, Cabenuva, with a median treatment duration of 18 months Among individuals switching to Cabenuva, 94% had a ...

At the European Society for Medical Oncology meeting this weekend, Merck will showcase three late-stage trials of its ...

Collaboration to explore how AI-facilitated technology can help make patient support programs more individualized, responsive ...

Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and ...

Securing financing that allowed an exit from academia, leaving ecology and evolutionary biology for biomedical engineering ...

The $100,000 H-1B visa fee has significantly affected who biopharma companies hire, according to two experts. It’s not the ...